A look back: Results from 1 year of routine clinical testing of both hematologic and solid tumors using two targeted next-generation sequencing (NGS) panels.
Robert D Daber
Honoraria - Illumina
Corey J. Langer
No relevant relationships to disclose
Selina M. Luger
No relevant relationships to disclose
Lynn Mara Schuchter
No relevant relationships to disclose
D. Gary Gilliland
No relevant relationships to disclose
David Roth
No relevant relationships to disclose
Martin Carroll
No relevant relationships to disclose
Katherine L. Nathanson
No relevant relationships to disclose
Jennifer J. Morrissette
No relevant relationships to disclose